I have great news to share with you. Amarantus Bioscience, a biotech company in San Francisco, has agreed to collaborate with our team to develop a novel treatment for blindness in Wolfram syndrome. It has been challenging to establish this collaboration because of several complicated issues. I was giving up at some point, but the Snow Foundation helped us establish this important collaboration. I would like to give you more detail after I speak with the CEO of the Amarantus. Here is the article published in the Wall Street Journal.